Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Christopher D.M. Fletcher, M.D., M.B.,B.S.

Co-Author

This page shows the publications co-authored by Christopher Fletcher and Vickie Jo.
Connection Strength

7.071
  1. SMARCB1/INI1 Loss in Epithelioid Schwannoma: A Clinicopathologic and Immunohistochemical Study of 65 Cases. Am J Surg Pathol. 2017 Aug; 41(8):1013-1022.
    View in: PubMed
    Score: 0.748
  2. Nuclear ß-Catenin Expression is Frequent in Sinonasal Hemangiopericytoma and Its Mimics. Head Neck Pathol. 2017 Jun; 11(2):119-123.
    View in: PubMed
    Score: 0.692
  3. Epithelioid malignant peripheral nerve sheath tumor: clinicopathologic analysis of 63 cases. Am J Surg Pathol. 2015 May; 39(5):673-82.
    View in: PubMed
    Score: 0.640
  4. Myoepithelial neoplasms of soft tissue: an updated review of the clinicopathologic, immunophenotypic, and genetic features. Head Neck Pathol. 2015 Mar; 9(1):32-8.
    View in: PubMed
    Score: 0.635
  5. WHO classification of soft tissue tumours: an update based on the 2013 (4th) edition. Pathology. 2014 Feb; 46(2):95-104.
    View in: PubMed
    Score: 0.587
  6. Paratesticular rhabdomyoma: a morphologically distinct sclerosing variant. Am J Surg Pathol. 2013 Nov; 37(11):1737-42.
    View in: PubMed
    Score: 0.577
  7. Cutaneous syncytial myoepithelioma: clinicopathologic characterization in a series of 38 cases. Am J Surg Pathol. 2013 May; 37(5):710-8.
    View in: PubMed
    Score: 0.557
  8. p63 immunohistochemical staining is limited in soft tissue tumors. Am J Clin Pathol. 2011 Nov; 136(5):762-6.
    View in: PubMed
    Score: 0.502
  9. Epithelioid rhabdomyosarcoma: clinicopathologic analysis of 16 cases of a morphologically distinct variant of rhabdomyosarcoma. Am J Surg Pathol. 2011 Oct; 35(10):1523-30.
    View in: PubMed
    Score: 0.499
  10. Atypical Pleomorphic Lipomatous Tumor: Expanding Our Current Understanding in a Clinicopathologic Analysis of 64 Cases. Am J Surg Pathol. 2021 09 01; 45(9):1282-1292.
    View in: PubMed
    Score: 0.248
  11. Pseudosarcomatous myofibroblastic proliferations of the urinary bladder are neoplasms characterized by recurrent FN1-ALK fusions. Mod Pathol. 2021 02; 34(2):469-477.
    View in: PubMed
    Score: 0.232
  12. Cutaneous Syncytial Myoepithelioma Is Characterized by Recurrent EWSR1-PBX3 Fusions. Am J Surg Pathol. 2019 10; 43(10):1349-1354.
    View in: PubMed
    Score: 0.217
  13. Recurrent SMARCB1 Inactivation in Epithelioid Malignant Peripheral Nerve Sheath Tumors. Am J Surg Pathol. 2019 06; 43(6):835-843.
    View in: PubMed
    Score: 0.212
  14. Expression of PAX3 Distinguishes Biphenotypic Sinonasal Sarcoma From Histologic Mimics. Am J Surg Pathol. 2018 10; 42(10):1275-1285.
    View in: PubMed
    Score: 0.203
  15. Immunohistochemical Detection and Molecular Characterization of IDH-mutant Sinonasal Undifferentiated Carcinomas. Am J Surg Pathol. 2018 08; 42(8):1067-1075.
    View in: PubMed
    Score: 0.200
  16. Chondromyxoid Fibroma Arising in Craniofacial Sites: A Clinicopathologic Analysis of 25 Cases. Am J Surg Pathol. 2018 03; 42(3):392-400.
    View in: PubMed
    Score: 0.195
  17. PHF1 fusions cause distinct gene expression and chromatin accessibility profiles in ossifying fibromyxoid tumors and mesenchymal cells. Mod Pathol. 2020 07; 33(7):1331-1340.
    View in: PubMed
    Score: 0.055
  18. Clinically Relevant Molecular Subtypes in Leiomyosarcoma. Clin Cancer Res. 2015 Aug 01; 21(15):3501-11.
    View in: PubMed
    Score: 0.040
  19. Recurrent rearrangement of the PHF1 gene in ossifying fibromyxoid tumors. Am J Pathol. 2012 Sep; 181(3):1069-77.
    View in: PubMed
    Score: 0.033
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.